Nilotinib monohydrochloride monohydrate is the hydrochloride monohydrate salt of nilotinib, a second-generation BCR-ABL tyrosine kinase inhibitor used in research to study BCR-ABL signaling, drug resistance, and mutant kinases. It is provided in concentrated stock-ready formats for biochemical, cell-based, and in vivo studies.
- Second-generation BCR-ABL tyrosine kinase inhibitor with activity against common resistant mutants.
- High chemical purity (~99.9% by LCMS) suitable for analytical and biological studies.
- Hydrochloride monohydrate salt form for improved solubility and handling.
- Molecular weight 583.99 g·mol⁻¹; formula C28H25ClF3N7O2.
- Soluble in DMSO (≈57 mM) and in acidified aqueous media; supplier provides stock preparation guidance.
- Intended for in vitro biochemical and cell-based assays and for in vivo formulation with appropriate vehicles.